Grindeks AS
GRD1R · Nasdaq Riga · Pharmaceuticals
Tentang perusahaan
Grindeks is Latvia's leading pharmaceutical manufacturer, producing original research compounds, generic medicines, and active pharmaceutical ingredients for export to over 50 countries. Its most well-known product is Mildronate (meldonium), a cardiovascular drug widely used in Eastern Europe and the CIS region. The company operates manufacturing facilities in Riga and has subsidiary operations across the Baltic and CIS markets.
| Bursa | Nasdaq Riga |
| Kode saham | GRD1R |
| Sektor | Pharmaceuticals |
| Kapitalisasi pasar indikatif USD | $55.00M |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (Nasdaq Riga), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Nasdaq Riga — pencatatan resmi di bursa
Hanya informasi ketersediaan — bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di Latvia
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset — bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.